Press release
North America Point-of-Care Diagnostics Market to Exceed USD 13.25 Billion by 2033, Driven by Rising Demand for Rapid Testing Solutions
According to market data by DataM Intelligence,the North America point-of-care diagnostics market size reached US$6.74 billion in 2024 and is expected to reach US$13.25 billion by 2033, growing at a CAGR of 7.9% during the forecast period 2025-2033.The North America point-of-care (POC) diagnostics market is revolutionizing healthcare by enabling rapid, decentralized testing with immediate clinical decision-making. POC diagnostics include devices and tests performed near the patient, outside traditional laboratory settings, providing results within minutes. This market is driven by the increasing prevalence of chronic diseases, demand for home-based testing, and technological advancements in portable diagnostic devices.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response):
https://www.datamintelligence.com/download-sample/north-america-point-of-care-diagnostics-market?sindhuri
Key growth factors include the rising geriatric population, increasing adoption of telehealth, and the need for faster diagnosis in emergency care. The infectious disease testing segment dominates due to high demand for rapid flu, HIV, and COVID-19 tests, while the U.S. holds the largest market share (over 85%) due to advanced healthcare infrastructure and favorable reimbursement policies.
Key Highlights from the Report
➤ The U.S. dominates with 85% market share, driven by high healthcare spending and rapid POC test adoption.
➤ Infectious disease testing leads the market due to increased demand for rapid flu, strep, and COVID-19 tests.
➤ Cardiometabolic testing is the fastest-growing segment, fueled by rising diabetes and heart disease cases.
➤ Hospitals & clinics are the largest end-users, but home care settings are growing rapidly.
➤ Technological advancements, such as smartphone-connected POC devices, are enhancing accessibility.
➤ FDA approvals for novel POC tests are accelerating market expansion.
Market Segmentation
The North America POC diagnostics market is segmented by product, application, end-user, and region.
By Product: Glucose monitoring devices dominate due to the diabetes epidemic, followed by infectious disease test kits and cardiac markers.
By Application: Infectious diseases hold the largest share, while cardiometabolic testing is growing fastest.
By End-User: Hospitals & clinics lead, but home care is expanding due to telehealth and remote monitoring trends.
Regional Insights
North America, led by the U.S., dominates due to high healthcare expenditure, strong regulatory support, and early adoption of POC technologies. Canada is growing steadily with government initiatives promoting decentralized testing.
Looking For a Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=north-america-point-of-care-diagnostics-market
Market Drivers
The shift toward decentralized healthcare, rising chronic disease prevalence, and increasing demand for rapid diagnostics are key drivers. The COVID-19 pandemic accelerated POC adoption, and ongoing telehealth integration sustains growth.
Market Restraints
High costs of advanced POC devices and regulatory challenges for new tests limit market expansion. Accuracy concerns with some rapid tests also hinder adoption.
Market Opportunities
Expansion of home-based testing, AI-integrated POC devices, and personalized medicine applications present significant growth opportunities.
Reasons to Buy the Report
✔ Market Overview & Growth Drivers
✔ Segmentation Insights
✔ Competitive Landscape
✔ Regulatory & Reimbursement Scenario
✔ Technological Advancements
✔ Country-Specific Analysis
✔ Challenges & Opportunities
✔ Strategic Takeaways for Stakeholders
Frequently Asked Questions (FAQs)
◆ How big is the North America POC diagnostics market?
◆ Which segment dominates the market by application?
◆ What is the projected growth rate through 2032?
◆ Which country leads in POC diagnostics adoption?
◆ How is telehealth influencing POC diagnostics growth?
Company Insights
◘Abbott
◘ Roche (F. Hoffmann-La Roche Ltd)
◘ Siemens Healthineers
◘ QuidelOrtho Corporation
◘ BD (Becton, Dickinson and Company)
◘ BioMérieux SA
◘ Danaher Corporation (including Cepheid)
◘ QIAGEN
◘ Nova Biomedical
◘ Trinity Biotech plc
Recent Developments:
Abbott launched a new handheld POC blood analyzer for critical care.
Roche received FDA approval for a rapid PCR-based POC COVID-19 test.
Speak to Our Analyst and Get Customization in the report as per your requirements:
https://www.datamintelligence.com/customize/north-america-point-of-care-diagnostics-market
Conclusion
The North America POC diagnostics market is poised for strong growth, driven by technological innovation, chronic disease burden, and healthcare decentralization. While cost and accuracy challenges persist, advancements in portable and connected diagnostics will shape the future of rapid testing. Companies investing in home-based and AI-enhanced POC solutions will lead the market.
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release North America Point-of-Care Diagnostics Market to Exceed USD 13.25 Billion by 2033, Driven by Rising Demand for Rapid Testing Solutions here
News-ID: 4149129 • Views: …
More Releases from DataM intelligence 4 Market Research LLP

United States Hybrid Energy Storage Market Projected to Expand at 6.89% CAGR, Re …
The global Hybrid Energy Storage Market reached US$ 16.56 billion in 2024 and is projected to reach US$ 28.22 billion by 2032, growing at a CAGR of 6.89% during the forecast period 2025-2032, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In September 2025, Tesla launched its next-generation Megapack 2.0 with integrated lithium-ion and flow battery technology for grid-scale applications.
✅ In August 2025, The Department of Energy announced $2.1…

United States Pyelonephritis Treatment Market Projected to Expand at 5.8% CAGR, …
The global Pyelonephritis Treatment Market reached US$ 1,014.39 million in 2024 and is projected to reach US$ 1,682.83 billion by 2033, growing at a CAGR of 5.8% during the forecast period 2025-2033, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In September 2025, The FDA approved a new extended-release antibiotic formulation for complicated urinary tract infections, including pyelonephritis.
✅ In August 2025, CDC updated treatment guidelines for antibiotic-resistant pyelonephritis cases,…

United States Uterine Cancer Treatment Market to Reach USD 39.0 Billion by 2033, …
The global Uterine Cancer Treatment Market reached US$ 23,633.46 Million in 2024 and is projected to reach US$ 39,007.22 Million by 2033, growing at a CAGR of 5.4% during the forecast period 2025-2033, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In September 2025, The FDA granted breakthrough therapy designation for Novartis' new targeted combination therapy for advanced endometrial cancer following promising Phase III trial results.
✅ In August 2025,…

United States Medical Device Contract Manufacturing Market 2025 | Growth Drivers …
Market Size and Growth
The global medical device contract manufacturing market size reached US$ 76.43 Billion in 2024 from US$ 69.54 Billion in 2023 and is expected to reach US$ 190.88 Billion by 2033, growing at a CAGR of 10.9% during the forecast period 2025-2033.
Key Development:
United States: Recent Industry Developments
✅ In August 2025, Flex Ltd. expanded its medical device outsourcing services for U.S. clients, focusing on design, prototyping, and full-scale manufacturing.
✅…
More Releases for POC
Primary Catalyst Driving POC Medical Imaging Market Evolution in 2025: Chronic D …
What market dynamics are playing a key role in accelerating the growth of the poc medical imaging market?
The escalating occurrence of long-term diseases is predicted to boost the expansion of the point-of-care medical imaging market in the future. The chronic disease prevalence pertains to the fraction or the count of people in a community affected by enduring health ailments at any given moment. This transition originates from lifestyle options, inherited…
Transforming the Point-of-Care (POC) Coagulation Testing Market in 2025: Cardiov …
"What Is the Expected Size and Growth Rate of the Point-of-Care (POC) Coagulation Testing Market?
The point-of-care (POC) coagulation testing market has grown significantly in recent years. It will grow from $1.18 billion in 2024 to $1.25 billion in 2025, at a CAGR of 5.8%. The growth is driven by increasing patient demand, the growing trend of point-of-care testing, high reliability in coagulation status testing, automation, integration with electronic health records…
POC Diagnostic Testing Devices | 1drop
1drop Inc.'s POC diagnostic testing devices are essential tools in modern healthcare, designed to deliver quick and accurate results for various health conditions at the point of care. These devices make diagnostics more accessible and timelier, enhancing healthcare delivery and patient outcomes.
Point-of-Care Molecular Diagnostic Platform
1drop offers a comprehensive POC molecular diagnostic platform that consists of three main components:
• Reagent: Specialized reagents formulated for specific tests, including molecular diagnostics.
• Device: The 1POT™ Duo…
POC Diagnostics Market Size 2024 to 2031.
Market Overview and Report Coverage
POC, or Point of Care, Diagnostics refer to medical tests that are performed outside of a traditional laboratory setting, allowing for quicker results and immediate treatment decisions. The POC Diagnostics Market encompasses a wide range of diagnostic tests including blood glucose monitoring, pregnancy tests, infectious disease testing, and more.
The future outlook of the POC Diagnostics Market is optimistic, with the market expected to grow…
Point of Care (POC) Coagulation Testing Devices Market - Transforming Coagulatio …
Newark, New Castle, USA: The "Point of Care (POC) Coagulation Testing Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Point of Care (POC) Coagulation Testing Devices…
POC Cardiovascular Diagnostic Market 2022 | Detailed Report
According to Market Study Report, POC Cardiovascular Diagnostic Market provides a comprehensive analysis of the POC Cardiovascular Diagnostic Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5467652
The report provides a comprehensive analysis of company profiles listed below:
- Abbott
- Biomerieux
- Danaher
- F.…